Catalog #RT60
Retatrutide
60 MG
Select Size:
Select Research Tier:
Batch-tested · Research-grade purity · Certificate of Analysis included
Quantity:
Line Total:
$240.00
Related Laboratory Supply
Laboratory Research Diluent — 0.9% Benzyl Alcohol is available separately for qualified laboratory workflows. Research use only. Not for human or animal use. Not for injection, diagnostic, clinical, therapeutic, or veterinary use.
View Laboratory Research Diluent →Technical Research Description
Retatrutide is a first-in-class triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. This unimolecular tri-agonist demonstrates balanced activity across all three receptor systems, enabling research into synergistic metabolic pathway modulation that cannot be achieved with single or dual agonists.
Simplified Explanation
This is a groundbreaking "triple-action" peptide that activates three different hormone receptors at once. It's the first compound of its kind that combines GLP-1, GIP, and glucagon receptor activation in a single molecule. Researchers are exploring how this triple approach affects energy balance and metabolism.
For Research Use Only
DISCLAIMER: This product is sold for research purposes only. Not for human consumption.
By purchasing, you confirm that you are a qualified researcher or represent a research institution, and that this product will be used solely for in-vitro research or lawful scientific study.
Certificate of Analysis (COA)
THIRD-PARTY VERIFIEDIndependent third-party HPLC and mass spectrometry analysis is provided for every batch.
Customer Reviews
No reviews yet — be the first to share your experience.
From Our Research Blog
Background reading and laboratory context for Retatrutide 60 MG — sourced from our research articles.
research
LC-120 Lipotropic Research Blend for Hepatic Lipid Flux
LC-120 is a ready-to-use lipotropic blend for in-vitro work on hepatic lipid transport, choline metabolism, and methionine-cycle b…
Jul 23, 2026
research
Tirzepatide: A dual incretin tool for metabolic work
Tirzepatide is a dual GIP/GLP-1 receptor agonist used in preclinical metabolic studies. Here's what to measure, control, and compa…
Jul 16, 2026
research
BPC-157 mechanism of action: current research
A research-first look at BPC-157: proposed signaling pathways, preclinical findings, key uncertainties, and what labs are studying…
Jul 15, 2026
research
RCM Precision Delivery Pen: Consistency in Handling
A research-focused look at the RCM Precision Delivery Pen and how consistent, low-fuss handling can tighten workflows for peptide …
Jul 13, 2026
research
Fat Loss vs. Muscle Loss in GLP-1 Research Today
GLP-1 research often shows weight reduction, but what's fat vs. lean mass? We unpack mechanisms, measurement pitfalls, and study d…
Jul 8, 2026
research
Survodutide and the GLP-1/Glucagon Research Split
Survodutide pairs GLP-1 and glucagon receptor agonism in one peptide. Here's what preclinical work suggests, and what to measure n…
Jul 8, 2026